• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Consumer Cyclical·FLMC.JK
Share

PT Falmaco Nonwoven Industri Tbk Stocks

IDR 144Last Updated 16.10.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

IDR 6.75M

IDR 144
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Falmaco Nonwoven Industri Tbk, established in 1996 and based in Padalarang, Indonesia, specializes in the production and global distribution of tissue products and nonwoven fabrics. The company offers a wide array of items, including moist towelettes, infant care essentials, daily personal hygiene wipes, and various other health-related commodities. Its extensive portfolio further encompasses nonwoven dry and sanitizing wash mitts, hospital-grade bedding, antiseptic hand gels, hand and surface disinfectant wipes, alcohol preparation pads, fogging solutions, sterile nonwoven medical dressings, sealed and unsealed protective coverall garments, surgical gowns and face masks, and single-use aprons.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 21:53

Apple Has Announced the Date of the Event Where It Will Unveil the First Touchscreen MacBook — Bloomberg

19.10.2026 21:49

"Davos in the Desert" has been postponed due to attacks. Fink and Solomon were scheduled to speak there.

19.10.2026 21:11

"Not all Neoclouds are the same": Experts recommend buying CoreWeave and Nebius after the market correction

19.10.2026 20:13

Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug

19.10.2026 18:43

"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026